ColaLife

23/01/2024

We are pleased to announce that we've had our 3rd peer-reviewed paper published in the academic press. This one describes HOIW we operated to achieve a scale-up in Zambia that has proved to be self-sustaining.

We are delighted to see our third peer-reviewed paper accepted and published by the prestigious Global Health Science and Practice, a journal that focusses on real world implementation and the ‘how’ of implementation. Having written on this blog so extensively about our work over the years this ...

23/01/2024

Here are our Top 5 highlights of 2023. Thanks to everyone who helped in achieving these...

2009’s top 10 | 2010’s top 10 | 2011’s top 10 | 2012’s top 10 | 2013’s top 10 2014’s top 10 | 2015’s top 10 | 2016’s top 10 | 2017’s top 10 | 2018’s top 10 2019’s top 5 | 2020’s top 5 | 2021’s top 3 | 2022’s top 5 This is the fifteenth and final […]

09/01/2024

Here are our Top 5 highlights for 2023. As always, thanks to everyone who’s helped us on the way.
https://www.colalife.org/2023/12/31/top-5-highlights-in-2023/

05/01/2023

2009's top 10 | 2010's top 10 | 2011's top 10 | 2012's top 10 | 2013's top 10 2014's top 10 | 2015's top 10 | 2016's top 10 | 2017's top 10 | 2018's top 10 2019's top 5 | 2020's top 5 | 2021's top 3 2022 saw us move to work more under the ORSZCA brand (the ORS/Zinc Co-pack Alliance) rather than ColaLife....

2009’s top 10 | 2010’s top 10 | 2011’s top 10 | 2012’s top 10 | 2013’s top 10 2014’s top 10 | 2015’s top 10 | 2016’s top 10 | 2017’s top 10 | 2018’s top 10 2019’s top 5 | 2020’s top 5 | 2021’s top 3 2022 saw us move to work more under the ORSZCA […]

08/06/2022

We are very pleased to share that the results of the ColaLife trial
have now been published in a peer-reviewed article by the BMJ. We wish to congratulate everybody involved in the trial and the subsequent scale-up in Zambia.
In 2019 the DHS survey estimated a national coverage of 35% of ORS+Zinc. That's up from around 1% before this work started.
This work was the launchpad for the application to WHO to change the recommendation that ORS and Zinc be co-packaged and the current effort, through ORSZCA, to accelerate the adoption of this new recommendation worldwide.

We are pleased to announce that the highlights of the ColaLife trial have now been published as a peer-reviewed paper by the BMJ in the BMJ’s Special Supplement on Social innovations in healt…

25/01/2022

Here are our top achievements for 2021 which all relate to the globalisation of our impact which we are doing through the establishment of the ORS/Zinc Co-pack Alliance (ORSZCA). Please sign up to ORSZCA and follow us on Twitter .

[Apologies for the delay in publishing this ‘end of year’ blog post.] 2009’s top 10 | 2010’s top 10 | 2011’s top 10 | 2012’s top 10 | 2013’s top 10 2014& #…

18/01/2022

Tomorrow (19-Jan) sees the launch of the ORS/Zinc Co-pack Alliance (ORSZCA) with contributions from the experts in this area from across the World. Register here:
https://jsi.zoom.us/meeting/register/tJcrf-ugqjgiGtYeCwukrkt62ylQ5My5hKvD
ORSZCA brings together key players to advocate for the rapid uptake of the new WHO recommendation that ORS and Zinc should be co-packaged. Our success will save hundreds of thousands of young lives.
Please join us.

17/08/2021

To help drive the uptake of co-packaged ORS and Zinc (the basis of our work in Zambia) we are catalysing the formation of the ORS/Zinc Co-pack Alliance (ORSZCA). Please nominate yourself or someone else as a co-chair...

Mother administers ORS to her child. ICDDR,B Hospital Dhaka © Bill & Melinda Gates Foundation/Prashant Panjiar As the world learns to live with COVID, ColaLife is re-starting its advocacy work …